apoQlar medical, founded in 2017 and headquartered in Germany, is a visionary in the healthcare sector. The company is dedicated to advancing medical practices through its groundbreaking HoloMedicine® technology. This innovation empowers healthcare professionals with immersive virtual and mixed reality environments, allowing for enhanced diagnostic precision, medical training, pre-operative planning, and patient education.
The slogan, "Experience Collaborative Medicine", reflects apoQlar medical's commitment to seamless integration into clinical workflows. By partnering with over 60 medical institutions worldwide, the company continually collaborates with healthcare professionals to ensure its solutions remain at the forefront of digital healthcare.
Attracting significant investor attention, apoQlar medical secured a €10.00M Series A investment from IFB Innovationsstarter GmbH and YZR Capital in May 2024. This financial backing underscores the confidence in the company's innovative approach and growth potential in the Health Care and Medical Devices industries.